# A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

> **NCT02553330** · PHASE2 · TERMINATED · sponsor: **Incyte Corporation** · enrollment: 90 (actual)

## Conditions studied

- Alopecia Areata

## Interventions

- **DRUG:** Placebo Cream
- **DRUG:** Ruxolitinib Phosphate Cream

## Key facts

- **NCT ID:** NCT02553330
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-11-18
- **Primary completion:** 2017-10-03
- **Final completion:** 2017-10-03
- **Target enrollment:** 90 (ACTUAL)
- **Why stopped:** The study was terminated early based on the results of a planned interim analysis.
- **Last updated:** 2020-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02553330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02553330, "A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02553330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*